Safe Stephen, Oany Arafat R, Tsui Wai Ning, Lee Miok, Srivastava Vinod, Upadhyay Srijana, Hailemariam Amanuel, Farkas Evan, Kakwan Sarah, Kearns Caitrina, Sivaram Gargi
Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX, USA.
Department of Biochemistry and Biophysics, Texas A&M University, College Station, TX, USA.
Transcription. 2025 Apr-Jun;16(2-3):224-260. doi: 10.1080/21541264.2025.2521766. Epub 2025 Jul 11.
The nuclear receptor (NR) superfamily of ligand-activated receptors plays a key role in maintaining cellular homeostasis and in pathophysiology. NRs can be subdivided into functional activities structural similarity and the existence of endogenous ligands. Most NRs are classified as those that are adopted orphan or orphan receptors which have only possible ligands or no identified endogenous ligands, respectively. In this review, the activities of the complete orphan receptor sub-family of transcription factors have been reviewed with a focus on the effects of possible endogenous (biochemicals), natural product-derived and synthetic ligands. Despite their lack of a bona-fide ligand, the orphan receptors bind structurally diverse compounds that exhibit tissue-specific agonist, antagonist and inverse agonist activities with potential for future development as clinical therapeutics for the treatment of multiple diseases.
配体激活受体的核受体(NR)超家族在维持细胞稳态和病理生理学中起关键作用。NR可根据功能活性、结构相似性和内源性配体的存在进行细分。大多数NR被分类为采用型孤儿受体或孤儿受体,分别只有可能的配体或未鉴定出内源性配体。在本综述中,对转录因子的完整孤儿受体亚家族的活性进行了综述,重点关注可能的内源性(生物化学物质)、天然产物衍生和合成配体的作用。尽管缺乏真正的配体,但孤儿受体能结合结构多样的化合物,这些化合物表现出组织特异性激动剂、拮抗剂和反向激动剂活性,具有作为多种疾病临床治疗药物未来开发的潜力。
Transcription. 2025
Psychopharmacol Bull. 2024-7-8
Health Technol Assess. 2006-9
Zhonghua Jie He He Hu Xi Za Zhi. 2025-3-12
2025-1
Cancers (Basel). 2025-1-17
Cell Death Dis. 2025-1-14
Adv Sci (Weinh). 2024-8
Genes (Basel). 2024-4-27
Biomolecules. 2024-2-27